- Home
- NVCR vs USA Comparison
NVCR vs USA Comparison
Compare NVCR & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- USA
- Stock Information
- Founded
- NVCR 2000
- USA 1986
- Country
- NVCR Switzerland
- USA United States
- Employees
- NVCR N/A
- USA N/A
- Industry
- NVCR Medical/Dental Instruments
- USA Finance Companies
- Sector
- NVCR Health Care
- USA Finance
- Exchange
- NVCR Nasdaq
- USA Nasdaq
- Market Cap
- NVCR 1.9B
- USA N/A
- IPO Year
- NVCR 2015
- USA N/A
- Fundamental
- Price
- NVCR $17.55
- USA $6.87
- Analyst Decision
- NVCR Buy
- USA
- Analyst Count
- NVCR 7
- USA 0
- Target Price
- NVCR $32.43
- USA N/A
- AVG Volume (30 Days)
- NVCR 1.3M
- USA 880.5K
- Earning Date
- NVCR 07-24-2025
- USA 01-01-0001
- Dividend Yield
- NVCR N/A
- USA 9.66%
- EPS Growth
- NVCR N/A
- USA N/A
- EPS
- NVCR N/A
- USA N/A
- Revenue
- NVCR $621,711,000.00
- USA N/A
- Revenue This Year
- NVCR $5.56
- USA N/A
- Revenue Next Year
- NVCR $9.19
- USA N/A
- P/E Ratio
- NVCR N/A
- USA N/A
- Revenue Growth
- NVCR 18.27
- USA N/A
- 52 Week Low
- NVCR $14.17
- USA $5.62
- 52 Week High
- NVCR $34.13
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- NVCR 48.98
- USA 59.95
- Support Level
- NVCR $16.81
- USA $6.84
- Resistance Level
- NVCR $18.59
- USA $6.94
- Average True Range (ATR)
- NVCR 0.70
- USA 0.06
- MACD
- NVCR 0.04
- USA 0.01
- Stochastic Oscillator
- NVCR 44.93
- USA 74.24
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.